摘要
目的:观察米非司酮与依沙丫啶联合用于中期引产的临床效果。方法:将中期引产的妊娠妇女100例,随机分为两组,其中对照组50例,依沙丫啶100mg羊膜腔内注射引产;观察组50例,米非司酮150mg分3次口服联合依沙丫啶100mg羊膜腔内注射引产。结果:观察组与对照组相比,宫缩发动时间提前,排胎时间短,引产成功率高,胎盘胎膜残留率低,产后出血少,无宫颈裂伤,差异有统计学意义(P<0.05)。结论:米非司酮与依沙丫啶联合应用引产时间短,成功率高,副作用小,是一种安全有效简单快速的终止中期妊娠的方法。
Objective: Isa mifepristone and acridine joint for medium-term clinical effect of induction of labor.Methods:The mediumterm induction of labor in pregnant women to 100 cases, randomly divided into two groups,In which 50 patients were treated, lsa amniotic injection of acridine 100mg induction of labor;Observation group, 50 cases of oral mifepristone 150mg divided into 3 sub-sand joint by intraamniotic injection of acridine 100mg induction.Results:Observed compared with the control group,the activation time of contraction in advance, exclusive tire a short time, induction of labor success rate,residual placenta is low, less postpartum bleeding, no cervical laceration, the difference was statistically significant (P〈0.05).Conclusions:Isa mifepristone abortion acridine combined a short time, success rate, side effects,ls an effective simple and fast method of termination of pregnancy, clinical effect.
出处
《中国医药导刊》
2011年第6期1014-1014,1016,共2页
Chinese Journal of Medicinal Guide
基金
河北省人口和计划生育委员会重点课题计划项目(编号:2010-C02)
关键词
米非司酮啶
依沙丫啶
中期引产
Mifepristone
Acridine by sand
Medium induction